{"id":{"repo_id":"birmingham","oai_identifier":"oai:etheses.bham.ac.uk:14605"},"canonical_url":"https://search.ndltd.org/etd/birmingham/oai:etheses.bham.ac.uk:14605","repository":{"repo_id":"birmingham","name":"University of Birmingham","base_url":"https://etheses.bham.ac.uk/cgi/oai2"},"display":{"title":"Postprandial aminoacidemia and appetite responses to a novel salmon-derived protein peptide in young healthy adults","abstract":"Muscle plays a vital role in our body’s health and relies on ingestion of amino acids in order to stimulate muscle protein synthesis (MPS). Research is endeavouring to search for novel, high-quality, sustainable protein sources, capable of supporting muscle mass globally. Marine protein hydrolysates offer a potential sustainable source of high-quality protein, although little research to-date has explored their postprandial aminoacidemic responses. This study investigated the postprandial aminoacidemic and appetite responses following ingestion of a novel Salmon Protein Peptide (SPP) supplement, compared with a dose-matched Milk Protein Isolate (MPI). 11 young healthy individuals (6 Male and 5 Female) took part in this randomized single-blind crossover study. After an overnight fast, participants consumed either SPP or MPI at a protein-matched dose of 0.3g/kg BM. Blood samples were taken before protein intake and periodically for 240minutes post-ingestion. Visual analog scales were utilized throughout to determine changes in perceived appetite, alongside a food diary and ad-libitum meal following the trial period to determine changes to dietary composition. Peak plasma values for total amino acid (SPP: 5004 ±296 vs. MPI: 3719 ±302μmol·L-1, p<0.001), non-essential amino acid (SPP: 3376 ±197 vs. MPI: 2287 ±173μmol·L-1, p<0.001), glycine (SPP: 456 ±24 vs. MPI: 284 ±33μmol·L-1, p<0.001), hydroxyproline (SPP: 74.9 ±6.6 vs. MPI: 28.3 ±2.6 μmol·L-1, p<0.001) and proline levels (SPP: 469 ±29 vs. MPI: 335 ±25 μmol·L-1, p=0.029) were significantly greater following SPP consumption and all demonstrated significantly greater iAUC values (all p<0.05). No differences were observed in plasma EAA levels between proteins (peak EAA levels = SPP: 1361 ±196 vs. MPI: 1340 ±166μmol·L-1, p=0.658; iAUC, p=0.551). Peak leucine levels did not significantly differ between proteins (SPP: 250 ±32 vs. MPI: 246 ±31μmol·L-1; p=0.657); however, leucine levels were significantly higher overall following MPI consumption (iAUC, p=0.011). Fat intake was significantly reduced compared to habitual diet following both SPP and MPI (1.0±0.6g/kg/day, p=0.0156; 1.0±0.4g/kg/day, p=0.0236, respectively). No differences in plasma insulin, glucose or appetite were observed between supplements. To conclude, SPP demonstrated great promise as a high-quality protein source when compared to MPI, although further investigation is needed to determine if SPP’s postprandial aminoacidemia can robustly stimulate MPS.","abstract_html":"Muscle plays a vital role in our body’s health and relies on ingestion of amino acids in order to stimulate muscle protein synthesis (MPS). Research is endeavouring to search for novel, high-quality, sustainable protein sources, capable of supporting muscle mass globally. Marine protein hydrolysates offer a potential sustainable source of high-quality protein, although little research to-date has explored their postprandial aminoacidemic responses. This study investigated the postprandial aminoacidemic and appetite responses following ingestion of a novel Salmon Protein Peptide (SPP) supplement, compared with a dose-matched Milk Protein Isolate (MPI). 11 young healthy individuals (6 Male and 5 Female) took part in this randomized single-blind crossover study. After an overnight fast, participants consumed either SPP or MPI at a protein-matched dose of 0.3g/kg BM. Blood samples were taken before protein intake and periodically for 240minutes post-ingestion. Visual analog scales were utilized throughout to determine changes in perceived appetite, alongside a food diary and ad-libitum meal following the trial period to determine changes to dietary composition. Peak plasma values for total amino acid (SPP: 5004 ±296 vs. MPI: 3719 ±302μmol·L-1, p&lt;0.001), non-essential amino acid (SPP: 3376 ±197 vs. MPI: 2287 ±173μmol·L-1, p&lt;0.001), glycine (SPP: 456 ±24 vs. MPI: 284 ±33μmol·L-1, p&lt;0.001), hydroxyproline (SPP: 74.9 ±6.6 vs. MPI: 28.3 ±2.6 μmol·L-1, p&lt;0.001) and proline levels (SPP: 469 ±29 vs. MPI: 335 ±25 μmol·L-1, p=0.029) were significantly greater following SPP consumption and all demonstrated significantly greater iAUC values (all p&lt;0.05). No differences were observed in plasma EAA levels between proteins (peak EAA levels = SPP: 1361 ±196 vs. MPI: 1340 ±166μmol·L-1, p=0.658; iAUC, p=0.551). Peak leucine levels did not significantly differ between proteins (SPP: 250 ±32 vs. MPI: 246 ±31μmol·L-1; p=0.657); however, leucine levels were significantly higher overall following MPI consumption (iAUC, p=0.011). Fat intake was significantly reduced compared to habitual diet following both SPP and MPI (1.0±0.6g/kg/day, p=0.0156; 1.0±0.4g/kg/day, p=0.0236, respectively). No differences in plasma insulin, glucose or appetite were observed between supplements. To conclude, SPP demonstrated great promise as a high-quality protein source when compared to MPI, although further investigation is needed to determine if SPP’s postprandial aminoacidemia can robustly stimulate MPS.","abstract_has_math":false,"creators":["Prosser, Sophie Paula"],"institution":"University of Birmingham","degree_name":"m_sc","degree_level":"m_sc","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2024,"date_issued":"2024-07","date_published":"2024-07","updated_at":"2026-11-19T09:32:40Z","subjects":["Q Science (General)","QM Human anatomy","QR Microbiology"],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[{"key":"person:identifier.orcid","label":"ORCID","values":["0000000197209510"],"render_values":[{"text":"0000-0001-9720-9510","href":"https://orcid.org/0000-0001-9720-9510","code":true}]}]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":"http://etheses.bham.ac.uk//id/eprint/14605/1/Prosser2024MSc.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://etheses.bham.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Aetheses.bham.ac.uk%3A14605","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.sponsor","label":"Sponsor","values":["na"]},{"key":"dc:creator","label":"Author","values":["Prosser, Sophie Paula"]},{"key":"person:identifier.orcid","label":"ORCID","values":["0000000197209510"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2024-07-11"]},{"key":"dc:date.issued","label":"Date","values":["2024-07"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["College of Life & Environmental Sciences","School of Sport, Exercise and Rehabilitation Sciences"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Birmingham"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["http://etheses.bham.ac.uk//id/eprint/14605/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["m_sc"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["m_sc"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Q Science (General)","QM Human anatomy","QR Microbiology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.dcterms_iso639_2","label":"Language (ISO 639-2)","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://etheses.bham.ac.uk//id/eprint/14605/1/Prosser2024MSc.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Muscle plays a vital role in our body’s health and relies on ingestion of amino acids in order to stimulate muscle protein synthesis (MPS). Research is endeavouring to search for novel, high-quality, sustainable protein sources, capable of supporting muscle mass globally. Marine protein hydrolysates offer a potential sustainable source of high-quality protein, although little research to-date has explored their postprandial aminoacidemic responses. This study investigated the postprandial aminoacidemic and appetite responses following ingestion of a novel Salmon Protein Peptide (SPP) supplement, compared with a dose-matched Milk Protein Isolate (MPI). 11 young healthy individuals (6 Male and 5 Female) took part in this randomized single-blind crossover study. After an overnight fast, participants consumed either SPP or MPI at a protein-matched dose of 0.3g/kg BM. Blood samples were taken before protein intake and periodically for 240minutes post-ingestion. Visual analog scales were utilized throughout to determine changes in perceived appetite, alongside a food diary and ad-libitum meal following the trial period to determine changes to dietary composition. Peak plasma values for total amino acid (SPP: 5004 ±296 vs. MPI: 3719 ±302μmol·L-1, p<0.001), non-essential amino acid (SPP: 3376 ±197 vs. MPI: 2287 ±173μmol·L-1, p<0.001), glycine (SPP: 456 ±24 vs. MPI: 284 ±33μmol·L-1, p<0.001), hydroxyproline (SPP: 74.9 ±6.6 vs. MPI: 28.3 ±2.6 μmol·L-1, p<0.001) and proline levels (SPP: 469 ±29 vs. MPI: 335 ±25 μmol·L-1, p=0.029) were significantly greater following SPP consumption and all demonstrated significantly greater iAUC values (all p<0.05). No differences were observed in plasma EAA levels between proteins (peak EAA levels = SPP: 1361 ±196 vs. MPI: 1340 ±166μmol·L-1, p=0.658; iAUC, p=0.551). Peak leucine levels did not significantly differ between proteins (SPP: 250 ±32 vs. MPI: 246 ±31μmol·L-1; p=0.657); however, leucine levels were significantly higher overall following MPI consumption (iAUC, p=0.011). Fat intake was significantly reduced compared to habitual diet following both SPP and MPI (1.0±0.6g/kg/day, p=0.0156; 1.0±0.4g/kg/day, p=0.0236, respectively). No differences in plasma insulin, glucose or appetite were observed between supplements. To conclude, SPP demonstrated great promise as a high-quality protein source when compared to MPI, although further investigation is needed to determine if SPP’s postprandial aminoacidemia can robustly stimulate MPS."]},{"key":"dc:format","label":"Dc Format","values":["text"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public"]},{"key":"dc:title","label":"Title","values":["Postprandial aminoacidemia and appetite responses to a novel salmon-derived protein peptide in young healthy adults"]}]}],"canonical_facts":{"dc:contributor.sponsor":["na"],"dc:creator":["Prosser, Sophie Paula"],"dc:date":["2024-07-11"],"dc:date.issued":["2024-07"],"dc:description.abstract":["Muscle plays a vital role in our body’s health and relies on ingestion of amino acids in order to stimulate muscle protein synthesis (MPS). Research is endeavouring to search for novel, high-quality, sustainable protein sources, capable of supporting muscle mass globally. Marine protein hydrolysates offer a potential sustainable source of high-quality protein, although little research to-date has explored their postprandial aminoacidemic responses. This study investigated the postprandial aminoacidemic and appetite responses following ingestion of a novel Salmon Protein Peptide (SPP) supplement, compared with a dose-matched Milk Protein Isolate (MPI). 11 young healthy individuals (6 Male and 5 Female) took part in this randomized single-blind crossover study. After an overnight fast, participants consumed either SPP or MPI at a protein-matched dose of 0.3g/kg BM. Blood samples were taken before protein intake and periodically for 240minutes post-ingestion. Visual analog scales were utilized throughout to determine changes in perceived appetite, alongside a food diary and ad-libitum meal following the trial period to determine changes to dietary composition. Peak plasma values for total amino acid (SPP: 5004 ±296 vs. MPI: 3719 ±302μmol·L-1, p<0.001), non-essential amino acid (SPP: 3376 ±197 vs. MPI: 2287 ±173μmol·L-1, p<0.001), glycine (SPP: 456 ±24 vs. MPI: 284 ±33μmol·L-1, p<0.001), hydroxyproline (SPP: 74.9 ±6.6 vs. MPI: 28.3 ±2.6 μmol·L-1, p<0.001) and proline levels (SPP: 469 ±29 vs. MPI: 335 ±25 μmol·L-1, p=0.029) were significantly greater following SPP consumption and all demonstrated significantly greater iAUC values (all p<0.05). No differences were observed in plasma EAA levels between proteins (peak EAA levels = SPP: 1361 ±196 vs. MPI: 1340 ±166μmol·L-1, p=0.658; iAUC, p=0.551). Peak leucine levels did not significantly differ between proteins (SPP: 250 ±32 vs. MPI: 246 ±31μmol·L-1; p=0.657); however, leucine levels were significantly higher overall following MPI consumption (iAUC, p=0.011). Fat intake was significantly reduced compared to habitual diet following both SPP and MPI (1.0±0.6g/kg/day, p=0.0156; 1.0±0.4g/kg/day, p=0.0236, respectively). No differences in plasma insulin, glucose or appetite were observed between supplements. To conclude, SPP demonstrated great promise as a high-quality protein source when compared to MPI, although further investigation is needed to determine if SPP’s postprandial aminoacidemia can robustly stimulate MPS."],"dc:format":["text"],"dc:identifier.uri":["http://etheses.bham.ac.uk//id/eprint/14605/1/Prosser2024MSc.pdf"],"dc:language.dcterms_iso639_2":["eng"],"dc:publisher.department":["College of Life & Environmental Sciences","School of Sport, Exercise and Rehabilitation Sciences"],"dc:publisher.institution":["University of Birmingham"],"dc:relation.isreferencedby":["http://etheses.bham.ac.uk//id/eprint/14605/"],"dc:subject":["Q Science (General)","QM Human anatomy","QR Microbiology"],"dcterms:accessrights":["public"],"dc:title":["Postprandial aminoacidemia and appetite responses to a novel salmon-derived protein peptide in young healthy adults"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["m_sc"],"dc:type.qualificationname":["m_sc"],"person:identifier.orcid":["0000000197209510"]},"updated_at":"2026-11-19T09:32:40Z"}